U.S. HEALTH

U.S. Diseases

FDA Accepted New Use for Kidney Disease Drug

FDA Accepted New Use for Kidney Disease Drug

The application seeks approval for KERENDIA to treat chronic kidney disease in adults without diabetes.

Live Poll

Do you trust pharmaceutical companies to prioritize treatment research for the most common chronic conditions?


Cancer

Live Poll

Do you believe partnerships between tech and pharma companies will make cancer treatments more accessible?

Cancer

Tempus, Moderna, and Merck Form Cancer Drug Partnership

The companies have partnered to advance development of a new melanoma treatment in development.

Tempus, Moderna, and Merck Form Cancer Drug Partnership

Autism

Live Poll

Should Nobel Prizes focus more on individual scientists or recognize the entire research team?

Autism

Optogenetics Researchers Have Won 2026 Nobel Prize

Three scientists were recognized for developing light-based tools that allow researchers to map and study the brain.

Optogenetics Researchers Have Won 2026 Nobel Prize

Stroke

Live Poll

Should hospitals rapidly transition to new medical technologies for standard clinical procedures?

Stroke

Smart Epidural Syringe Adopted by 30 Hospitals

A new device aims to help clinicians identify the epidural space more accurately using real-time pressure feedback.

Smart Epidural Syringe Adopted by 30 Hospitals

Diabetes

Diabetes

Developers Advanced Needle-Free Diabetes Drug Options

New non-invasive delivery methods aim to improve treatment adherence for patients with needle phobia.


Allergies

Live Poll

Do you believe new pharmaceutical treatments for chronic skin conditions will improve your overall quality of life?

Allergies

FDA Approved First Treatment for Symptomatic Dermographism

Adults with chronic hives unresponsive to antihistamines may soon have a new, FDA-approved prescription option.

FDA Approved First Treatment for Symptomatic Dermographism

More in Diseases